Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2005
10/05/2005CN1221536C New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication
10/05/2005CN1221534C Substited 8-arylquinoline phosphodiesterase-4 inhibitors
10/05/2005CN1221533C 7-amino-1H-indole derivatives
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221262C Phthalazine derivatives for treating inflammatory diseases
10/05/2005CN1221254C New combination of serotonin agonist (5HT2) and antagonist (5HT6) as pharmaceutical formulation
10/04/2005US6951949 such as 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide for treatment of arthritis
10/04/2005US6951944 Production of imidazole derivatives and novel intermediates of the derivatives
10/04/2005US6951874 Compounds
10/04/2005US6951872 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
10/04/2005US6951871 Indole derivatives useful as histamine H3 antagonists
10/04/2005US6951864 4-imidazol-1-ylmethyl-pyrimidine derivatives
10/04/2005US6951862 Calcium channel blockers comprising two benzhydril moieties
10/04/2005US6951861 Chemical compounds
10/04/2005US6951858 Substituted 1,2,4-triazine-3,5-diones; male and female sex hormone related conditions
10/04/2005US6951856 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
10/04/2005US6951849 Psychological disorders; central nervous system disorders; schizophrenia
10/04/2005US6951848 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
10/04/2005CA2146763C Quinolone and acridinone derivatives for the treatment of urinary incontinence
09/2005
09/29/2005WO2005090347A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
09/29/2005WO2005090333A1 3-‘4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
09/29/2005WO2005090332A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005WO2005090331A1 Polymorphic and amorphous forms of 2,5-dimethyl-2h-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indasol-6-ylamino]-phenyl}-amide
09/29/2005WO2005090330A1 N-piperidine derivates as ccr3 modulators
09/29/2005WO2005090329A1 New compounds for the inhibition of angiogenesis and use of thereof
09/29/2005WO2005090328A1 Heterocyclic compound and use thereof
09/29/2005WO2005090320A2 Triazole derivatives and method of using the same to treat hiv infections
09/29/2005WO2005090314A1 1-phenyl and 1-pyridylpyrazole derivatives and their use as pesticides
09/29/2005WO2005090313A1 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides
09/29/2005WO2005090312A1 5-aminoalkylpyrazole derivatives as pesticidal agents
09/29/2005WO2005090311A1 Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/29/2005WO2005090308A1 Process for the synthesis of a cxcr4 antagonist
09/29/2005WO2005090305A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
09/29/2005WO2005090304A1 Organic compounds
09/29/2005WO2005090303A1 4- (5- (aminomethyl) -indole-1-ylmethyl) -benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity
09/29/2005WO2005090302A2 Palladium catalyzed indolization of 2-bromo or chloroanilines
09/29/2005WO2005090300A1 Novel benzyl(idene)-lactam derivatives
09/29/2005WO2005089770A1 Benzodiazepines for treating or preventing or preventing rsv infection
09/29/2005WO2005089551A1 Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides
09/29/2005WO2005089511A2 Novel pharmaceutical forms, and methods of making and using the same
09/29/2005WO2005073224A3 Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
09/29/2005WO2005073195A3 Hcv ns-3 serine protease inhibitors
09/29/2005WO2005065183A3 Mitotic kinesin inhibitors
09/29/2005WO2005063721B1 Herbicidal pyrimidines
09/29/2005WO2005060947A3 Agonist and antagonist ligands of the nociceptin receptor
09/29/2005WO2005051917A9 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
09/29/2005WO2005035495B1 Fibrinogen receptor antagonists and their use
09/29/2005WO2005025507A3 Dihydropyridine compounds for treating or preventing metabolic disorders
09/29/2005WO2005023192A3 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
09/29/2005WO2005016916A3 Substituted quinolines serving as antimicrobial agents
09/29/2005WO2004106299A8 Substituted pyrrole derivatives and their use as hmg-co inhibitors
09/29/2005WO2004105752A8 Substituted pyrrole derivatives as hmg-coa reductase inhibitors
09/29/2005US20050215799 reacting aryl/heteroaryl triflate/halide with carbon monoxide and N-hydroxysuccinimide in solvent in presence of palladium catalyst and base
09/29/2005US20050215798 Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215785 Reacting methanesulfonyl chloride with 3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxylic acid, reacting with 2-amino-3-methyl-5-chlorobenzoic acid to produce -[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]-6-chloro-8-methyl-4H-3,1-benzoxazin-4-one
09/29/2005US20050215784 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
09/29/2005US20050215614 Substituted indoles and their use as hcv inhibitors
09/29/2005US20050215610 Such as 3-(4-(2-[2-(3,5-Difluoro-phenyl)-acetylamino]-pentanoylamino)-imidazol-1-yl)-butyric acid methyl ester; secretase, A beta -peptide inhibitor; neurogenerative and neurological diseases: Alzheimer's disease; Notch signaling pathway inhibitor; antiinflammatory agent, asthma, autoimmune diseases
09/29/2005US20050215599 Pyrrolidine-3,4-dicarboxamide derivatives
09/29/2005US20050215593 Kaposi's sarcoma; Crohn's disease
09/29/2005US20050215589 Inhibitors of 5-HT2A receptor
09/29/2005US20050215588 Pyridyl cyanoguanidine compounds, e.g., 1-[2-(4-Piperidyl)-ethoxy-carbonyloxymethyl]-4-[N'-cyano-N''-(6-(4-chloro-phenoxy)-1-hexyl)-N-guanidino]-pyridinium chloride, hydrochloride; human and veterinary therapy of proliferative diseases such as cancers
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005US20050215577 Tetrahydrocarbazoles and derivatives
09/29/2005US20050215576 antagonists of calcitonin gene-related peptide receptors (CGRP-receptor); 3-(7-Methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl 4-(1,2-dihydro-2-oxoquinazolin-3(4H)-yl)piperidine-1-carboxylate for example
09/29/2005US20050215575 Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
09/29/2005US20050215574 4-anilino quinazoline derivatives as antiproliferative agents
09/29/2005US20050215560 5-{2-[4-[1-(4-fluoro-2-hydroxy-phenyl)-methanoyl]-piperidine-1-yl]-(ethyl or propyl)amino}-(optional 2-alkyl)-2H-pyridazine-3-one; hydrogenation of the isoxazolyl-alkylamino-pyridazinone; anxiolytic agents
09/29/2005US20050215559 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders
09/29/2005US20050215553 For therapy and prophylaxis of cardiovascular, central nervous system, inflammatory, and bone diseases as well as infectious diseases and certain cancers
09/29/2005US20050215550 Pyrazole-derived kinase inhibitors and uses thereof
09/29/2005US20050215546 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carboxylic acid-{(R)-2-(4-amino-3,5-dibromo-phenyl)-1-[1-(3-dimethylamino-propyl)-1H-benzimidazol-2-yl]-ethyl}-amide; calcitonin gene related peptide antagonist; antiinflammatory agent, vasodilator, arthritis, asthma, diabetes type 2
09/29/2005US20050215542 Compounds for the treatment of diseases
09/29/2005US20050215526 Melanin concentrating hormone receptor antagonist
09/29/2005US20050214568 Aromatic terpolymers based on monomers comprising a fluorene, (9-phenyl-9-(4-bromomethylphenyl)-2,7-dibromofluorene), an imide (4-N,N-di(4-bromophenyl)-9-(4-t-butylphenyl)-1,8-naphthalimide),and a tertiary-amine (N,N'-di(4-methylphenyl)-N,N'-di(4-bromophenyl)-1,4-phenylenediamine); displays; industrial
09/29/2005US20050214204 [18F][2-fluorodideuteromethoxy-5-(5-trifluoromethyl-tetrazol-1-yl)-benzyl]-([2S,3S]-2-phenyl-piperidin-3-yl)-amine; image of neurokinin-1 receptors using positron emission tomography; detection or quantification; bioassay; brain, tissues, inflammation where substance P is involved, Alzheimer's disease
09/29/2005DE102004012365A1 Substituierte Dihydropyridine Substituted dihydropyridines
09/29/2005DE102004012070A1 Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel New cycloalkyl-containing 5-Acylindolinone, their preparation and their use as medicaments
09/29/2005DE102004012068A1 Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel New alkyl-containing 5-Acylindolinone, their preparation and their use as medicaments
09/29/2005DE102004011705A1 Substituierte 4-(4-Trifluormethylpyrazolyl)-Pyrimidine Substituted 4- (4-Trifluormethylpyrazolyl) -pyrimidines
09/29/2005DE102004001873A1 Cyanopyrimidinone Cyanopyrimidinone
09/29/2005CA2560286A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005CA2560199A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
09/29/2005CA2560195A1 Organic compounds
09/29/2005CA2559639A1 Polymorphic and amorphous forms of 2,5-dimethyl-2h-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indasol-6-ylamino]-phenyl}-amide
09/29/2005CA2559221A1 Methods for the treatment of synucleinopathies
09/29/2005CA2559097A1 Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides
09/29/2005CA2558389A1 Process for the synthesis of a cxcr4 antagonist
09/29/2005CA2558058A1 N-piperidine derivates as ccr3 modulators
09/29/2005CA2558051A1 Palladium catalyzed indolization of 2-bromo or chloroanilines
09/29/2005CA2558030A1 4- (5- (aminomethyl) -indole-1-ylmethyl) -benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity
09/29/2005CA2557929A1 Benzodiazepines for treating or preventing or preventing rsv infection
09/29/2005CA2557730A1 Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/29/2005CA2554610A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
09/28/2005EP1578755A1 Phosphonooxy quinazoline derivatives and their pharmaceutical use
09/28/2005EP1578744A1 Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists
09/28/2005EP1578743A2 Antibacterial agents
09/28/2005EP1578742A1 Process for preparing optically pure active compounds
09/28/2005EP1578737A1 Substituted heterocyclic compounds
1 ... 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 ... 1080